article thumbnail

SCOTUS rejects UnitedHealth appeal of Medicare Advantage overpayment rule

Healthcare Dive

The justices declined to take up the case, leaving intact a lower court ruling that backed the 2014 CMS regulation requiring swift return of overpayments.

article thumbnail

Aetna may have received $25.5M in MA overpayments for 2015 and 2016, audit finds

Healthcare Dive

Medical records provided by the insurer didn’t support certain diagnosis codes, resulting in overpayments, according to an audit from the HHS’ Office of the Inspector General.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medicare Advantage overpayments could exceed $75B this year, study finds

Healthcare Dive

The figure is almost triple prior estimates of MA overpayments, highlighting the need for payment reform to avoid overtaxing the Medicare system, researchers said.

article thumbnail

$29M Overpayment Case: A Costly Lesson in Compliance

Healthicity

The case revolves around a New York-based healthcare organization that allegedly retained overpayments from the Uniformed Services Family Health Plan (USFHP), a Department of Defense (DoD) health plan serving military personnel, retirees, and their families.

article thumbnail

PBM practices are keeping consumers from generics savings, white paper finds

Healthcare Dive

Consumers are overpaying for generic drug prescriptions by as much as 20% due to pharmacy benefit manager practices like copay clawbacks and spread pricing, researchers found.

article thumbnail

Humana sues HHS over Medicare Advantage audits

Healthcare Dive

The payer, which brings in the bulk of its revenue from Medicare, is fighting back against a rule finalized earlier this year to claw back overpayments in the increasingly popular MA program.

Medicare 301
article thumbnail

Judge dismisses lawsuit against Wells Fargo over prescription drug costs

Healthcare Dive

The decision could throw cold water on potential copycat suits seeking to hold large, self-funded employers responsible if they overpay for prescription drugs.